TNC and neoplasm: Given that TNC expression was found elevated from 0% in benign prostatic hyperplasia (BPH) stroma to 47% in tumor-associated stroma [29], its detection in circulation [47] and its immunomodulatory role [48] indicate TNC as a promising drug target and disease-determining factor.